Estro Formula
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80042121
- Status
- Active licence
- Licence date
- 6 May 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Solanum lycopersicum Source : Chair (fruit) Potency : 2.5 mg Lycopene | 50 mg | Not calculated |
| Sel de calcium acide d-Glucarique (1:1) Source : Calcium D-saccharate | 75 mg | Not calculated |
| Rosmarinus officinalis Source : Feuille Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 75 mg | 12.5 mg | Not calculated |
| Brassica oleracea var. italica Source : Plante entière Potency : 100 mcg Sulforaphane | 27.5 mg | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 30:1 Dry plant equivalent : 1,500 mg Potency : 80 % Catechins | 50 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 1 % Caffeine | Not specified | Not calculated |
| 3-hydroxyméthylindole Source : Indole-3-carbinol | 75 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Silice, NA, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 day |
Uses authorised in Canada
Helps to support/promote (healthy) estrogen metabolism (and promote/support a healthy estrogen metabolism ratio). Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you are pregnant or breastfeeding, or if you have iron deficiency. Consult a physician prior to use if you have a liver disease or develop symptoms of liver trouble. Consult a physician if you have gallstones or a bile duct obstruction. Consult a physician if you have stomach ulcers or excess stomach acids. Consult a physician if you are taking any medication. Consult a physician prior to use if you are attempting to conceive. Consult a physician prior to use if you are taking antiplatelet medication or blood thinners. Consult a physician prior to use if you have low estrogen or symptoms of low estrogen. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
Source
Official Health Canada record, licence 80042121
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.